PAINREFORM LTD (PRFX)
IL0011651580 - Common Stock
PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File
Targeting to commence second part of Phase 3 clinical trial in mid-Q4 2023 Trial completion and results expected in mid-2024 TEL AVIV, Israel, Sept. 11,...
PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary
Professor Eli Hazum to Share Positive Safety and PK Data of PRF-110 from First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing...
PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City
TEL AVIV, Israel, Sept. 05, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...
PainReform Provides Business Update for the Second Quarter of 2023
Targeting to commence second part of Phase 3 clinical trial in bunionectomy during the fourth quarter of 2023...
7 Stocks Under $10 to Buy for August
Stocks under $10 have many advantages, so it pays to see which has the best potential for growth. The Portfolio Grader can help with that.
Why Is Discover Financial (DFS) Stock Down 13% Today?
Discover Financial (DFS) stock is falling on Thursday after the financial services company revealed it's undergoing a regulatory review.
Why Is Netcapital (NCPL) Stock Down 42% Today?
Netcapital (NCPL) stock is dropping on Thursday after the fintech company announced the pricing of a public share offering.
Why Is Eliem Therapeutics (ELYM) Stock Up 6% Today?
Eliem Therapeutics (ELYM) stock is taking off on Thursday after the biotechnology company announced plans to explore strategic alternatives.
Why Is PainReform (PRFX) Stock Up 38% Today?
PainReform (PRFX) stock is rallying on Thursday after the pharmaceutical company regained compliance with Nasdaq listing requirements.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning!
PainReform regains compliance with Nasdaq's minimum bid price rule (NASDAQ:PRFX)
PainReform (PRFX) said on Wednesday that the specialty pharmaceutical company has regained compliance with Nasdaq's minimum bid price requirement.
PainReform Regains Compliance with Nasdaq Continued Listing Requirements
TEL AVIV, Israel, July 19, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!
PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement
TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...
PRFX Stock: The $2.7 Million Reason PainReform Is Up 100% Today
Here's what investors should be watching with PainReform, as PRFX stock more than doubles in an incredible session today.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off Thursday with a look at the biggest pre-market stock movers traders will want to keep an eye on this morning.
SPWR Stock Alert: Can SunPower Double From Here?
SunPower (SPWR) stock is on the move Wednesday as one analyst predicts the company's shares could more than double in value!
Why Is PainReform (PRFX) Stock Down 40% Today?
PainReform (PRFX) stock is falling on Wednesday after the company announced a concurrent registered direct offering and private placement.
PainReform prices 301,230 shares at $9.00 in registered direct offering (NASDAQ:PRFX)
PainReform (PRFX) has entered into a definitive agreement for the purchase and sale of 301,230 of the Co.’s ordinary shares, at a purchase price of $9/ordinary share, in a...
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
TEL AVIV, Israel, July 12, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start off Wednesday with an overview of all the biggest pre-market stock movers worth watching this morning!